Navigation Links
Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards

MOUNTAIN VIEW, Calif., March 16 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the firm will be naming the recipients of its 2009 Excellence in Medical Technologies & Life Sciences Awards. The Awards will be announced during a banquet that will take place on Wednesday, March 18, 2009 in San Francisco.


The Medical Technologies & Life Sciences Awards are given to companies that have made a significant contribution to the pharmaceutical, biotech, drug discovery, clinical diagnostics, medical imaging, and medical device industries. Such companies have shown success at meeting the needs of patients and other stakeholders in the healthcare industry, while building world-class companies with strong management teams.

The evening will feature a CEO Roundtable session titled, "CEO Insights: Healthcare and Life Sciences Growth Leadership Panel," in which five senior-level executives will discuss how they have been able to address challenges and still realize growth.

"The Award recipients are pioneers in the industry," explains Frost & Sullivan's Director of Healthcare Research Monali Patel Shastry. "The Awards recognize innovation and an unflinching commitment to serving their end-users and providing value to the industry as a whole."

To choose Award recipients, Frost & Sullivan's healthcare analyst team tracks emerging and existing markets and evaluates the contributions of industry participants. Analysts quantify several market factors for each participant according to predetermined criteria that define innovation in medical technologies and life sciences. The analysts also consider the pace of technology development and deployment, and the potential relevance or significance of the innovation to the overall industry. The Award recipient is ultimately chosen after a thorough evaluation of this research.

The Awards banquet will take place from 5:00 p.m. until 10:00 p.m. on Wednesday, March 18, 2009 at the Hyatt Fisherman's Wharf, located at 555 North Point Street, San Francisco, California 94133. For more information, please contact Jake Wengroff, Global Director, Corporate Communications, at 210.247.3806 or

The Awards banquet will be co-located with 14th Annual Medical Devices 2009: A Frost & Sullivan Executive MindXchange, taking place March 15-17, 2009.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit

    Jake Wengroff

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence
2. Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies
3. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
4. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
5. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
6. Frost & Sullivan Names Naviscan a Leader in the Future of Molecular Breast Imaging
7. Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
8. Frost & Sullivan Sees Microdosing as Compelling Advantage for Big Pharma
9. Frost & Sullivan Recognizes ESBATechs Innovation in Developing Antibody Fragments for Biologic Therapeutics
10. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
11. Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support
Post Your Comments:
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
Breaking Biology News(10 mins):